Context: Prenatal testing aims to identify fetal chromosomal and genetic disorders prior to delivery. Current invasive procedures such as amniocentesis and chorionic villus sampling (CVS) pose a risk to mother and fetus and such diagnostic procedures are available only to high-risk pregnancies, which limits aneuploidy detection rate. The identification of cell-free fetal DNA (cffDNA) in maternal circulation has made noninvasive prenatal testing (NIPT) possible. This review seeks to highlight the necessity of investing in NIPT and briefly summarizes the technical aspects of the NIPT and application of this method in clinical practice. Evidence Acquisition: PubMed, OVID, SCOPUS, and the Cochrane database were searched for relevant articles pu...
Fetal aneuploidies are among the most common causes of miscarriages, perinatal mortality and neurode...
Recent advances in molecular genetic technologies have facilitated non-invasive prenatal testing (NI...
Non-invasive prenatal screening (NIPS) offers an opportunity to screen or determine features associa...
BACKGROUND: Cell-free fetal DNA (cffDNA) is present in the maternal blood from around 4 weeks gestat...
Non-invasive prenatal diagnosis using cell-free fetal nucleic acids in maternal plasma: Progress ove...
Recent works have discovered, the focus on prenatal diagnosis have now opened up new start for a mor...
Cell-free DNA (cf DNA) testing has recently become indispensable in diagnostic testing and screening...
New tools for higher-resolution fetal genome analysis including microarray and next-generation seque...
Prenatal testing is important for the early detection and diagnosis of rare genetic conditions with ...
Nowadays, the use of cell-free fetal DNA (cfDNA) is a promising tool in clinical practice as a poten...
Objective Analyze the economic value of replacing conventional fetal aneuploidy screening approaches...
Treball de fi de grau en Biologia HumanaSupervisor: Vincenzo CiriglianoPrenatal screening and diagno...
© 2018 Elsevier Ltd New tools for higher-resolution fetal genome analysis including microarray and n...
Megan Allyse,1 Mollie A Minear,2 Elisa Berson,3 Shilpa Sridhar,3 Margaret Rote,3 Anthony Hung,3 Subh...
Non-invasive prenatal testing (NIPT) for fetal aneuploidy detection is increasingly being offered in...
Fetal aneuploidies are among the most common causes of miscarriages, perinatal mortality and neurode...
Recent advances in molecular genetic technologies have facilitated non-invasive prenatal testing (NI...
Non-invasive prenatal screening (NIPS) offers an opportunity to screen or determine features associa...
BACKGROUND: Cell-free fetal DNA (cffDNA) is present in the maternal blood from around 4 weeks gestat...
Non-invasive prenatal diagnosis using cell-free fetal nucleic acids in maternal plasma: Progress ove...
Recent works have discovered, the focus on prenatal diagnosis have now opened up new start for a mor...
Cell-free DNA (cf DNA) testing has recently become indispensable in diagnostic testing and screening...
New tools for higher-resolution fetal genome analysis including microarray and next-generation seque...
Prenatal testing is important for the early detection and diagnosis of rare genetic conditions with ...
Nowadays, the use of cell-free fetal DNA (cfDNA) is a promising tool in clinical practice as a poten...
Objective Analyze the economic value of replacing conventional fetal aneuploidy screening approaches...
Treball de fi de grau en Biologia HumanaSupervisor: Vincenzo CiriglianoPrenatal screening and diagno...
© 2018 Elsevier Ltd New tools for higher-resolution fetal genome analysis including microarray and n...
Megan Allyse,1 Mollie A Minear,2 Elisa Berson,3 Shilpa Sridhar,3 Margaret Rote,3 Anthony Hung,3 Subh...
Non-invasive prenatal testing (NIPT) for fetal aneuploidy detection is increasingly being offered in...
Fetal aneuploidies are among the most common causes of miscarriages, perinatal mortality and neurode...
Recent advances in molecular genetic technologies have facilitated non-invasive prenatal testing (NI...
Non-invasive prenatal screening (NIPS) offers an opportunity to screen or determine features associa...